Related Articles for PubMed (Select 15642174)

Deficits in plasma oestradiol measurement in studies and management of breast cancer.

Dowsett M, Folkerd E.

Breast Cancer Res. 2005;7(1):1-4. Epub 2004 Oct 28. Review.

PMID: 15642174 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Pre-operative oestradiol levels - relation to survival in breast cancer.

Holmberg L, Nordén T, Lindgren A, Wide L, Degerman M, Adami HO.

Eur J Surg Oncol. 2001 Mar;27(2):152-6.

PMID: 11289750 [PubMed - indexed for MEDLINE]

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.

PMID: 15840882 [PubMed - indexed for MEDLINE]

Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.

Geisler J, Haynes B, Ekse D, Dowsett M, Lønning PE.

J Steroid Biochem Mol Biol. 2007 Apr;104(1-2):27-34. Epub 2007 Mar 9.

PMID: 17350249 [PubMed - indexed for MEDLINE]

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.

J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.

PMID: 16418513 [PubMed - indexed for MEDLINE]

Limitations of direct estradiol and testosterone immunoassay kits.

Stanczyk FZ, Cho MM, Endres DB, Morrison JL, Patel S, Paulson RJ.

Steroids. 2003 Dec;68(14):1173-8.

PMID: 14643879 [PubMed - indexed for MEDLINE]

Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.

Tamimi RM, Byrne C, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2007 Aug 1;99(15):1178-87. Epub 2007 Jul 24.

PMID: 17652278 [PubMed - indexed for MEDLINE]

Measuring serum oestradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method.

Hogervorst E, Williams J, Combrinck M, David Smith A.

Eur J Endocrinol. 2003 Jan;148(1):67-72.

PMID: 12534359 [PubMed - indexed for MEDLINE]

Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.

J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15.

PMID: 17018787 [PubMed - indexed for MEDLINE]

10:

Genistein stimulates growth of human breast cancer cells in a novel, postmenopausal animal model, with low plasma estradiol concentrations.

Ju YH, Allred KF, Allred CD, Helferich WG.

Carcinogenesis. 2006 Jun;27(6):1292-9. Epub 2006 Mar 14.

PMID: 16537557 [PubMed - indexed for MEDLINE]

11:

Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.

Eliassen AH, Tworoger SS, Hankinson SE.

Int J Cancer. 2007 Apr 1;120(7):1536-41.

PMID: 17211859 [PubMed - indexed for MEDLINE]

12:

Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.

Hernández L, Nuñez-Villarl MJ, Martínez-Arribas F, Pollán M, Schneider J.

Anticancer Res. 2005 Jan-Feb;25(1B):451-4.

PMID: 15816610 [PubMed - indexed for MEDLINE]

13:

The relationship between factors affecting endogenous oestradiol levels in postmenopausal women and breast cancer.

Folkerd EJ, Martin LA, Kendall A, Dowsett M.

J Steroid Biochem Mol Biol. 2006 Dec;102(1-5):250-5. Epub 2006 Oct 17. Review.

PMID: 17049846 [PubMed - indexed for MEDLINE]

14:

Enhancement of the sensitivity of a chemiluminescent immunoassay for estradiol based on hapten heterology.

Sato H, Mochizuki H, Tomita Y, Kanamori T.

Clin Biochem. 1996 Dec;29(6):509-13.

PMID: 8939397 [PubMed - indexed for MEDLINE]

15:

Prospective breast cancer risk prediction model for women undergoing screening mammography.

Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, Tice JA, Buist DS, Geller BM, Rosenberg R, Yankaskas BC, Kerlikowske K.

J Natl Cancer Inst. 2006 Sep 6;98(17):1204-14.

PMID: 16954473 [PubMed - indexed for MEDLINE]

16:

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.

Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A, Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, van Gils CH, Grobbee D, Boeing H, Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiébaut A, González CA, Quirós JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P, Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E.

Endocr Relat Cancer. 2005 Dec;12(4):1071-82.

PMID: 16322344 [PubMed - indexed for MEDLINE]

17:

Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.

Schernhammer ES, Holly JM, Pollak MN, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):699-704.

PMID: 15767352 [PubMed - indexed for MEDLINE]

18:

Serum vascular endothelial growth factor in breast cancer.

Byrne GJ, McDowell G, Agarawal R, Sinha G, Kumar S, Bundred NJ.

Anticancer Res. 2007 Sep-Oct;27(5B):3481-7.

PMID: 17972505 [PubMed - indexed for MEDLINE]